Market Cap | ₹44Cr |
ROE | -4.40% |
P/E Ratio(TTM) | -42.07 |
EPS(TTM) | -0.44 |
P/B Ratio | 1.78 |
Dividend Yield | 0.00% |
Industry P/E | 40.33 |
Book Value | 10.40 |
Debt to Equity | 0.02 |
Face Value | 10 |
Parent Organisation | Kabra Drugs Limited |
BSE Symbol | 524322 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 59.50 | ||
Gland Pharma | NA (0.00%) | 41.26 | ||
Ajanta Pharma | NA (0.00%) | 32.48 | ||
Eris Lifesciences | NA (0.00%) | 53.35 |